Attachment A - Price Schedule.xlsx
XLSX spreadsheet 102 KB Posted
- Attached to
- 6550--ROCHE 5800 CPT IDIQ
- Solicitation number
- 36C26226Q0192
About this file
This document is a detailed Price Schedule (Attachment A) for a Department of Veterans Affairs (VA) VISN 22 Network solicitation for Roche Cobas 5800 Infectious Molecular Pathology Cost Per Test (CPT) contract. The pricing document outlines estimated annual test volumes and costs for multiple molecular diagnostic tests across seven VA medical facilities, including Prescott, Loma Linda, Long Beach, West Los Angeles, Phoenix, Tucson, and Albuquerque. The tests include HIV-1 Viral Load, Hepatitis C/B Viral Load, CT/NG, HPV, SARS-CoV-2, flu A/B, RSV, and other specialized viral load and qualitative tests, with a total estimated annual volume of 81,541 tests.
The document is part of a pre-solicitation Request for Information (RFI) seeking potential qualified sources under NAICS code 325413 with a size standard of 1,250 employees. The VA is specifically seeking providers who can deliver molecular pathology testing services using the Roche Cobas 5800 platform across VISN 22 locations. The pricing schedule includes detailed breakdowns of estimated test volumes by site, with a 5% repeat rate factored in, and provides a framework for potential vendors to understand the scope and scale of the anticipated contract, which covers a base year plus three option years with estimated 3% annual increases.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| Attachment B - SOW.docx | DOCX document | |
| 36C26226Q0192.docx | DOCX document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
1. VISN CPT
| Test Description | TOTAL CPT (Years 1 -4 ALL INCLUSIVE) | VISN 22 ESTIMATED ANNUAL TEST VOLUME | VISN 22 ESTIMATED ANNUAL EXTENDED COST | |||||
| BASE YEAR | Option Year 1 | Option Year 2 | Option Year 3 | VISN 22 Estimated 4-Year Test Total | ||||
| BASE YEAR | Option Year 1 | Option Year 2 | Option Year 3 | VISN 22 Estimated 4-Year Test Extended Price |
| estimated 3% increase | estimated 3% increase | estimated 3% increase | |||||||||
| HIV-1 Viral Load | $ - 0 | 10,832 | 11,157 | 11,492 | 11,837 | 45,318 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| Hepatitis C Viral Load | $ - 0 | 5,629 | 5,798 | 5,972 | 6,151 | 23,550 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| Hepatitis B Viral Load | $ - 0 | 2,299 | 2,368 | 2,439 | 2,512 | 9,618 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| CT/NG | $ - 0 | 39,492 | 40,677 | 41,897 | 43,154 | 165,220 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| HPV | $ - 0 | 9,591 | 9,879 | 10,175 | 10,480 | 40,125 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| SARS-CoV-2 | $ - 0 | 11,578 | 11,925 | 12,283 | 12,651 | 48,437 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| SAR-CoV-2, flu A/B, RSV | $ - 0 | 310 | 319 | 329 | 339 | 1,297 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| TV/MG | $ - 0 | 1,610 | 1,658 | 1,708 | 1,759 | 6,735 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| HIV 1, 2 Qualitative (confirmatory) | $ - 0 | 103 | 106 | 109 | 112 | 430 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| CMV Viral Load | $ - 0 | 41 | 42 | 43 | 44 | 170 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| EBV Viral load | $ - 0 | 15 | 15 | 15 | 15 | 60 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| BKV Viral load | $ - 0 | 41 | 42 | 43 | 44 | 170 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| Service | $ - 0 | 8 | 8 | 8 | 24 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||
| 81,541 | 83,986 | 86,505 | 89,098 | 341,130 | $ - 0 |
&"-,Bold"ATTACHMENT C
2. EST ANNUAL SITE VOL
| Prescott | Loma Linda | Long Beach | West Los Angeles | Phoenix | Tucson | Albuquerque | VISN 22 TOTAL ANNUAL VOLUME | ||||||||||||||||
| Est. Test Volume | 5% Repeat Rate | Total | Est. Test Volume | 5% Repeat Rate | Total | Est. Test Volume | 5% Repeat Rate | Total | Est. Test Volume | 5% Repeat Rate | Total | Est. Test Volume | 5% Repeat Rate | Total | Est. Test Volume | 5% Repeat Rate | Total | Est. Test Volume | 5% Repeat Rate | Total | |||
| HIV-1 Viral Load | - 0 | - 0 | - 0 | - 0 | - 0 | 6,928 | 346 | 7,274 | - 0 | - 0 | - 0 | - 0 | 2,989 | 149 | 3,138 | 400 | 20 | 420 | 10,832 | ||||
| Hepatitis C Viral Load | - 0 | - 0 | - 0 | - 0 | - 0 | 3,683 | 184 | 3,867 | - 0 | - 0 | - 0 | - 0 | 1,078 | 54 | 1,132 | 600 | 30 | 630 | 5,629 | ||||
| Hepatitis B Viral Load | - 0 | - 0 | - 0 | - 0 | - 0 | 2,189 | 109 | 2,298 | - 0 | - 0 | - 0 | - 0 | - 0 | - 0 | - 0 | 1 | - 0 | 1 | 2,299 | ||||
| CT/NG | 100 | 5 | 105 | 4,000 | 200 | 4,200 | 18,321 | 916 | 19,237 | 9,408 | 470 | 9,878 | 4,132 | 207 | 4,339 | - 0 | - 0 | 1,650 | 83 | 1,733 | 39,492 | ||
| HPV | 232 | 12 | 244 | 900 | 45 | 945 | 4,001 | 200 | 4,201 | 852 | 43 | 895 | 1,451 | 73 | 1,524 | 947 | 47 | 994 | 750 | 38 | 788 | 9,591 | |
| SARS-CoV-2 | - 0 | - 0 | 2,000 | 100 | 2,100 | 6,826 | 341 | 7,167 | 2,000 | 100 | 2,100 | 200 | 10 | 210 | - 0 | - 0 | 1 | - 0 | 1 | 11,578 | |||
| SAR-CoV-2, flu A/B, RSV | - 0 | - 0 | 59 | 3 | 62 | 59 | 3 | 62 | 59 | 3 | 62 | 59 | 3 | 62 | - 0 | - 0 | 59 | 3 | 62 | 310 | |||
| TV/MG | - 0 | - 0 | - 0 | - 0 | - 0 | 767 | 38 | 805 | - 0 | - 0 | 767 | 38 | 805 | - 0 | - 0 | - 0 | - 0 | - 0 | 1,610 | ||||
| HIV 1, 2 Qualitative (confirmatory) | - 0 | - 0 | - 0 | - 0 | - 0 | 98 | 5 | 103 | - 0 | - 0 | - 0 | - 0 | - 0 | - 0 | - 0 | - 0 | - 0 | 103 | |||||
| CMV Viral Load | - 0 | - 0 | - 0 | - 0 | - 0 | 39 | 2 | 41 | - 0 | - 0 | - 0 | - 0 | - 0 | - 0 | - 0 | - 0 | - 0 | 41 | |||||
| EBV Viral load | - 0 | - 0 | - 0 | - 0 | 14 | 1 | 15 | - 0 | - 0 | - 0 | - 0 | - 0 | - 0 | - 0 | - 0 | - 0 | 15 | ||||||
| BKV Viral load | - 0 | - 0 | - 0 | - 0 | 39 | 2 | 41 | - 0 | - 0 | - 0 | - 0 | - 0 | - 0 | - 0 | - 0 | - 0 | 41 | ||||||
| Total | 332 | 17 | 349 | 6,959 | 348 | 7,307 | 42,964 | 2,147 | 45,111 | 12,319 | 616 | 12,935 | 6,609 | 331 | 6,940 | 5,014 | 250 | 5,264 | 3,461 | 174 | 3,635 | 81,541 |
3. REAGENT CPT
| COST PER TEST | ||||
| (Cost of single test ALL INCLUSIVE: reagents, supplies, consumables, training, delivery, software licenses, etc.) | Please identify what Reagents and Consumables are required to run a single test | PART NUMBER | COST PER KIT | QUANTITY PER KIT |
| HIV-1 Viral Load | $0.00 | (Example) |
Hepatitis C Viral Load $0.00 (Example)
Hepatitis B Viral Load $0.00 (Example)
CT/NG $0.00 (Example)
HPV $0.00 (Example)
SARS-CoV-2 $0.00 (Example)
SAR-CoV-2, flu A/B, RSV $0.00 (Example)
TV/MG $0.00 (Example)
HIV 1, 2 Qualitative (confirmatory) $0.00 (Example)
CMV Viral Load $0.00 (Example)
EBV Viral load $0.00 (Example)
BKV Viral load $0.00 (Example)
4. SERVICE
| Annual Service Cost (as outlined in SOW) | Prescott | Loma Linda | Long Beach | West Los Angeles | Phoenix | Tucson | New Mexico | TOTAL ANNUAL SERVICE COST |
| Cobas 5800 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $0.0000 |
| $0.0000 |
5. OTHER
| OTHER HARDWARE / SOFTWARE / SERVICES | ||||||||
| (Do not include software licenses, include licenses in Service) | Part/Product # | Prescott | Loma Linda | Long Beach | West Los Angeles | Phoenix | Tucson | New Mexico |
| DESCRIPTION | Indicate quantity per site | |||||||
| middleware initial cost (Example) | ||||||||
| Training Slot (Example) | TR1 |
6. ADDITIONAL PRICING SHEET
| Item / Reagent | Item number | ||||
| OEM | Unit of Measure | COST | Comments | ||
| Individual site move for LL | LL1 | JB | $15,000.0000 | (Example) | |
| Individual site move for LB | LB2 | JB | $23,000.0000 | (Example) | |
| Reagent X | x59604 | BX | $300.0000 | (Example) |
File details come from the government source that posted it. Updated .